FERGUSON STRATEGIES, LLC for C.R. BARD INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
H.R. 2146, the "Trade Preferences Extension Act." Policy issues relating to the Trans-Pacific Partnership trade agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
Taxation/Internal Revenue Code TAX
H.R. 160, the Protect Medical Innovation Act. S.149, the Medical Device Access and Innovation Protection Act. H.R. 880, the American Research and Competitiveness Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
Health Issues HCR
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry. H.R. 1078, the "Food and Drug Administration Safety Over Sequestration Act." H.R. 160, the"Protect Medical Innovation Act. S. 149, the "Medical Device Access and Innovation Protection Act." S. 1077, the "Advancing Breakthrough Devices for Patients Act." S. 1622, the "FDA Device Accountability Act." S. 2737, the "Improving Medical Device Innovation Act." Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program. Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.